Specific Oculomotor Deficits After Amylobarbitone
Overview
Authors
Affiliations
Five healthy volunteers received a single oral dose of amylobarbitone sodium (200 mg) and placebo in a double blind randomized fashion. Peak velocity of horizontal saccadic eye movements, saccade duration and smooth pursuit velocity were measured at intervals up to 6 h after drug administration. The active treatment produced a statistically significant decrease of both saccadic and smooth pursuit eye velocity. The maximum effect was observed 2 h after drug administration. The effect on peak saccadic velocity was still statistically significant 6 h after treatment. The maximum impairment in eye movement performance ranged between 25 and 29%. These results demonstrate that both saccadic and smooth pursuit systems are unable to generate the required eye velocity under the influence of a therapeutic dose of amylobarbitone sodium.
Effect of amphetamine on saccadic and smooth pursuit eye movements.
Tedeschi G, Bittencourt P, Smith A, Richens A Psychopharmacology (Berl). 1983; 79(2-3):190-2.
PMID: 6405428 DOI: 10.1007/BF00427810.
Saccadic eye movement analysis as a measure of drug effects on human psychomotor performance.
Griffiths A, Marshall R, Richens A Br J Clin Pharmacol. 1984; 18 Suppl 1:73S-82S.
PMID: 6151850 PMC: 1463359. DOI: 10.1111/j.1365-2125.1984.tb02584.x.
Cohen A, Ashby L, Crowley D, Land G, Peck A, Miller A Br J Clin Pharmacol. 1985; 20(6):619-29.
PMID: 4091994 PMC: 1400839. DOI: 10.1111/j.1365-2125.1985.tb05120.x.
Oculomotor control in Gilles de la Tourette syndrome.
Bollen E, Roos R, Cohen A, Minderaa R, Reulen J, van de Wetering B J Neurol Neurosurg Psychiatry. 1988; 51(8):1081-3.
PMID: 3216209 PMC: 1033119. DOI: 10.1136/jnnp.51.8.1081.
Saccadic eye movements analysis as a measure of drug effect on central nervous system function.
Tedeschi G, Quattrone A, Bonavita V Ital J Neurol Sci. 1986; 7(2):223-31.
PMID: 2873111 DOI: 10.1007/BF02230885.